Artificial intelligence in drug discovery
Artificial intelligence (AI) is revolutionizing drug discovery by accelerating the identification and development of new therapeutic compounds, improving target selection, and optimizing various stages of the drug development process. Here's an overview of the role of AI in drug discovery.
Related Conference of Artificial intelligence in drug discovery
Artificial intelligence in drug discovery Conference Speakers
Recommended Sessions
- Advances in analytical techniques
- Adverse drug reactions
- Artificial intelligence in drug discovery
- Challenges in translating research to practice
- Clinical trial design and compliance
- Drug pricing and affordability
- Ethical considerations in drug development
- Medicinal chemistry approaches for specific diseases
- Nanotechnology in drug delivery
- Natural products in drug discovery
- Preclinical and clinical studies
- Rational drug design
Related Journals
Are you interested in
- Biochemistry - Glycobiology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)